Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 31;20(1):2387461.
doi: 10.1080/21645515.2024.2387461. Epub 2024 Aug 16.

The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis

Liuliu Quan  1   2 , Jiawen Dai  3   4 , Yuan Luo  5 , Lin Wang  6 , Yue Liu  5 , Jiaqi Meng  5 , Fan Yang  5 , Xin You  2   7
Affiliations
Review

The 100 top-cited studies in systemic lupus erythematosus: A bibliometric analysis

Liuliu Quan et al. Hum Vaccin Immunother. .

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune inflammatory tissue disease. In view of the explosive growth in research on SLE, bibliometrics was performed to evaluate the 100 top-cited papers in this realm. We performed the search with terms "systemic lupus erythematosus" the Web of Science Core Collection database on May 3, 2023. Relevant literatures were screened. Data were extracted and analyzed by SPSS. The citations of 100 top-cited SLE studies spanned from 472 to 13,557. Most studies (60 out of 100) were conducted in the United States. Total citation times were positively associated with ACY, which was negatively correlated with the length of time since publication. Approximately half of the studies focused on the underlying mechanisms of SLE. New biologic therapies garnered attention and development. Our findings provide valuable insights into the developments in crucial areas of SLE and shed contributions to future studies.

Keywords: Systemic lupus erythematosus; bibliometric analysis; bibliometrics; citations; literature review; research hotspots.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Institutions of the corresponding author in the 100 top-cited studies.
Figure 2.
Figure 2.
Years of the 100 top-cited studies on SLE.
Figure 3.
Figure 3.
Country distribution of the 100 top-cited studies on SLE.
Figure 4.
Figure 4.
Correlation analysis between ACY and publication time.
Figure 5.
Figure 5.
Correlation analysis between total citation times and ACY.
See this image and copyright information in PMC

References

    1. Mok CC, Lau CS.. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481–16. doi: 10.1136/jcp.56.7.481. - DOI - PMC - PubMed
    1. Borchers AT, Keen CL, Shoenfeld Y, Gershwin ME. Surviving the butterfly and the wolf: mortality trends in systemic lupus erythematosus. Autoimmun Rev. 2004;3(6):423–53. doi: 10.1016/j.autrev.2004.04.002. - DOI - PubMed
    1. Barber MRW, Drenkard C, Falasinnu T, Hoi A, Mak A, Kow NY, Svenungsson E, Peterson J, Clarke AE, Ramsey-Goldman R. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515–32. doi: 10.1038/s41584-021-00668-1. - DOI - PMC - PubMed
    1. Casciolarosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in 2 populations of surface-structures on apoptotic keratinocytes. J Exp Med. 1994;179(4):1317–30. doi: 10.1084/jem.179.4.1317. - DOI - PMC - PubMed
    1. Cheema GS, Roschke V, Hilbert DA, Stohl W. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001;44(6):1313–19. doi: 10.1002/1529-0131(200106)44:6<1313:aid-art223>3.0.co;2-s. - DOI - PubMed

LinkOut - more resources